Here are five things to know:
1. Zacks presently has a $21 price target on Exactech’s stock.
2. Exactech has a one-year low of $16.11 and a one-year high of $26.20.
3. The stock’s 50 day moving average is $17.63 and its 200-day moving average is $18.77.
4. The stock has a market cap of $259.46 million.
5. On average, Exactech has an average rating of “buy” and a consensus target price of $25.
More articles on devices:
Researchers make new discovery on bone fracture healing: 5 key notes
SeaSpine signs 3-year, $30M credit facility: 5 key notes
Stryker director sells 18k shares, following Smith & Nephew acquisition rumors: 7 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
